Intestinal Multi-Target Mechanisms of Natural Active Substances in Hyperuricemia Alleviation: Recent Progress.
Ying Chen1, Ziling Pan1, Hongyan Li1
1Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Beijing 100080, China.
Natural compounds target the intestine to regulate uric acid (UA) levels, offering a safer approach to managing hyperuricemia. This review explores gut mechanisms and natural substances for potential new treatments.
Area of Science:
- Metabolic disorders
- Gastroenterology
- Pharmacology
Background:
- Hyperuricemia, characterized by high serum uric acid (UA), leads to gout and kidney issues.
- Current treatments for hyperuricemia often cause adverse effects.
- The intestine is recognized as a key regulator of UA homeostasis, presenting a new therapeutic target.
Purpose of the Study:
- To review intestinal mechanisms controlling UA regulation.
- To evaluate natural active substances targeting these gut-mediated pathways for hyperuricemia treatment.
Main Methods:
- Systematic review of preclinical studies on intestinal UA metabolism.
- Analysis of gut microbiota, urate transporters, barrier function, and inflammation.
- Evaluation of natural substances like polyphenols, polysaccharides, and peptides.
Main Results:
- Natural substances modulate gut microbiota composition.
- These substances enhance UA intestinal excretion and intestinal barrier function.
- Natural compounds effectively suppress inflammatory pathways linked to hyperuricemia.
Conclusions:
- Natural active substances demonstrate multi-target efficacy in the intestine for hyperuricemia.
- Intestinal interventions using natural compounds offer a promising therapeutic strategy.
- Further research into nutrition-based and pharmacological treatments targeting the gut is warranted.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Antihypertensive Drugs: Action of Diuretics
Drug Elimination by Renal Route: Tubular Secretion
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Urinary Tract Calculi III: Medical Management
